Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway

From bedside to bench and back

Katherine A. Rauen, Lisa Schoyer, Frank McCormick, Angela E. Lin, Judith E. Allanson, David A. Stevenson, Karen W. Gripp, Giovanni Neri, John C. Carey, Eric Legius, Marco Tartaglia, Suzanne Schubbert, Amy E. Roberts, Bruce D. Gelb, Kevin Shannon, David H. Gutmann, Martin McMahon, Carmen Guerra, James A. Fagin, Benjamin Yu & 17 others Yoko Aoki, Benjamin G. Neel, Allan Balmain, Richard R. Drake, Garry P. Nolan, Martin Zenker, Gideon Bollag, Judith Sebolt-Leopold, Jackson B. Gibbs, Alcino J. Silva, E. Elizabeth Patton, David H. Viskochil, Mark W. Kieran, Bruce R. Korf, Randi J. Hagerman, Roger J. Packer, Teri Melese

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.

Original languageEnglish
Pages (from-to)4-24
Number of pages21
JournalAmerican Journal of Medical Genetics, Part A
Volume152
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Mitogen-Activated Protein Kinases
Costello Syndrome
Musculoskeletal Abnormalities
LEOPARD Syndrome
Skin Abnormalities
Eye Abnormalities
Gene Components
Neurofibromatosis 1
Germ-Line Mutation
Practice Guidelines
Clinical Trials
Students
Physicians
Research
Neoplasms
Therapeutics

Keywords

  • Cardio-facio-cutaneous syndrome
  • Clinical trial
  • Costello syndrome
  • Legius syndrome
  • Neurofibromatosis type 1
  • Noonan syndrome
  • Ras/MAPK
  • RASopathy
  • Signal transduction pathway
  • Therapy

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Rauen, K. A., Schoyer, L., McCormick, F., Lin, A. E., Allanson, J. E., Stevenson, D. A., ... Melese, T. (2010). Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. American Journal of Medical Genetics, Part A, 152(1), 4-24. https://doi.org/10.1002/ajmg.a.33183

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway : From bedside to bench and back. / Rauen, Katherine A.; Schoyer, Lisa; McCormick, Frank; Lin, Angela E.; Allanson, Judith E.; Stevenson, David A.; Gripp, Karen W.; Neri, Giovanni; Carey, John C.; Legius, Eric; Tartaglia, Marco; Schubbert, Suzanne; Roberts, Amy E.; Gelb, Bruce D.; Shannon, Kevin; Gutmann, David H.; McMahon, Martin; Guerra, Carmen; Fagin, James A.; Yu, Benjamin; Aoki, Yoko; Neel, Benjamin G.; Balmain, Allan; Drake, Richard R.; Nolan, Garry P.; Zenker, Martin; Bollag, Gideon; Sebolt-Leopold, Judith; Gibbs, Jackson B.; Silva, Alcino J.; Patton, E. Elizabeth; Viskochil, David H.; Kieran, Mark W.; Korf, Bruce R.; Hagerman, Randi J.; Packer, Roger J.; Melese, Teri.

In: American Journal of Medical Genetics, Part A, Vol. 152, No. 1, 01.2010, p. 4-24.

Research output: Contribution to journalArticle

Rauen, KA, Schoyer, L, McCormick, F, Lin, AE, Allanson, JE, Stevenson, DA, Gripp, KW, Neri, G, Carey, JC, Legius, E, Tartaglia, M, Schubbert, S, Roberts, AE, Gelb, BD, Shannon, K, Gutmann, DH, McMahon, M, Guerra, C, Fagin, JA, Yu, B, Aoki, Y, Neel, BG, Balmain, A, Drake, RR, Nolan, GP, Zenker, M, Bollag, G, Sebolt-Leopold, J, Gibbs, JB, Silva, AJ, Patton, EE, Viskochil, DH, Kieran, MW, Korf, BR, Hagerman, RJ, Packer, RJ & Melese, T 2010, 'Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back', American Journal of Medical Genetics, Part A, vol. 152, no. 1, pp. 4-24. https://doi.org/10.1002/ajmg.a.33183
Rauen, Katherine A. ; Schoyer, Lisa ; McCormick, Frank ; Lin, Angela E. ; Allanson, Judith E. ; Stevenson, David A. ; Gripp, Karen W. ; Neri, Giovanni ; Carey, John C. ; Legius, Eric ; Tartaglia, Marco ; Schubbert, Suzanne ; Roberts, Amy E. ; Gelb, Bruce D. ; Shannon, Kevin ; Gutmann, David H. ; McMahon, Martin ; Guerra, Carmen ; Fagin, James A. ; Yu, Benjamin ; Aoki, Yoko ; Neel, Benjamin G. ; Balmain, Allan ; Drake, Richard R. ; Nolan, Garry P. ; Zenker, Martin ; Bollag, Gideon ; Sebolt-Leopold, Judith ; Gibbs, Jackson B. ; Silva, Alcino J. ; Patton, E. Elizabeth ; Viskochil, David H. ; Kieran, Mark W. ; Korf, Bruce R. ; Hagerman, Randi J. ; Packer, Roger J. ; Melese, Teri. / Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway : From bedside to bench and back. In: American Journal of Medical Genetics, Part A. 2010 ; Vol. 152, No. 1. pp. 4-24.
@article{9aab8dad238e4e3f80ecb6872ba75dac,
title = "Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back",
abstract = "The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium {"}Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back{"} chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.",
keywords = "Cardio-facio-cutaneous syndrome, Clinical trial, Costello syndrome, Legius syndrome, Neurofibromatosis type 1, Noonan syndrome, Ras/MAPK, RASopathy, Signal transduction pathway, Therapy",
author = "Rauen, {Katherine A.} and Lisa Schoyer and Frank McCormick and Lin, {Angela E.} and Allanson, {Judith E.} and Stevenson, {David A.} and Gripp, {Karen W.} and Giovanni Neri and Carey, {John C.} and Eric Legius and Marco Tartaglia and Suzanne Schubbert and Roberts, {Amy E.} and Gelb, {Bruce D.} and Kevin Shannon and Gutmann, {David H.} and Martin McMahon and Carmen Guerra and Fagin, {James A.} and Benjamin Yu and Yoko Aoki and Neel, {Benjamin G.} and Allan Balmain and Drake, {Richard R.} and Nolan, {Garry P.} and Martin Zenker and Gideon Bollag and Judith Sebolt-Leopold and Gibbs, {Jackson B.} and Silva, {Alcino J.} and Patton, {E. Elizabeth} and Viskochil, {David H.} and Kieran, {Mark W.} and Korf, {Bruce R.} and Hagerman, {Randi J.} and Packer, {Roger J.} and Teri Melese",
year = "2010",
month = "1",
doi = "10.1002/ajmg.a.33183",
language = "English",
volume = "152",
pages = "4--24",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway

T2 - From bedside to bench and back

AU - Rauen, Katherine A.

AU - Schoyer, Lisa

AU - McCormick, Frank

AU - Lin, Angela E.

AU - Allanson, Judith E.

AU - Stevenson, David A.

AU - Gripp, Karen W.

AU - Neri, Giovanni

AU - Carey, John C.

AU - Legius, Eric

AU - Tartaglia, Marco

AU - Schubbert, Suzanne

AU - Roberts, Amy E.

AU - Gelb, Bruce D.

AU - Shannon, Kevin

AU - Gutmann, David H.

AU - McMahon, Martin

AU - Guerra, Carmen

AU - Fagin, James A.

AU - Yu, Benjamin

AU - Aoki, Yoko

AU - Neel, Benjamin G.

AU - Balmain, Allan

AU - Drake, Richard R.

AU - Nolan, Garry P.

AU - Zenker, Martin

AU - Bollag, Gideon

AU - Sebolt-Leopold, Judith

AU - Gibbs, Jackson B.

AU - Silva, Alcino J.

AU - Patton, E. Elizabeth

AU - Viskochil, David H.

AU - Kieran, Mark W.

AU - Korf, Bruce R.

AU - Hagerman, Randi J.

AU - Packer, Roger J.

AU - Melese, Teri

PY - 2010/1

Y1 - 2010/1

N2 - The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.

AB - The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.

KW - Cardio-facio-cutaneous syndrome

KW - Clinical trial

KW - Costello syndrome

KW - Legius syndrome

KW - Neurofibromatosis type 1

KW - Noonan syndrome

KW - Ras/MAPK

KW - RASopathy

KW - Signal transduction pathway

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=75149112680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149112680&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33183

DO - 10.1002/ajmg.a.33183

M3 - Article

VL - 152

SP - 4

EP - 24

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 1

ER -